$1,069.75 travel Payment -- Novartis Pharmaceuticals to Dr. Thomas Miller

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Novartis Pharmaceuticals made a $1.1K travel payment to Thomas Miller, a Ophthalmology specialist in City, MO. Thomas Miller received $1069.75 from Novartis Pharmaceuticals for travel and lodging expenses on October 9, 2024. The payment was categorized as 'travel' and specifically for 'Travel and Lodging'. This payment was made to an ophthalmologist in Missouri.

Patient Guidance: What This Payment Means for You

This information relates to payments made to healthcare providers for travel and lodging. It is important to understand the nature of these payments and how they might relate to your healthcare. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments are common in the pharmaceutical industry, particularly for educational events or consultations. The amount and nature of this specific payment should be considered in the context of typical industry practices for ophthalmology.

Regulatory Context: Sunshine Act Requirements

This record is part of the CMS Open Payments program, which aims to increase transparency around financial relationships between the healthcare industry and physicians.

Related Topics

This payment is related to the following healthcare transparency topics:

• cms-open-payments
• pharma-payments
• ophthalmology
• travel-and-lodging
• novartis-pharmaceuticals
• physician-payments

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $1.1K payment for?

This was a travel payment of $1.1K from Novartis Pharmaceuticals to Thomas Miller, categorized as "Travel and Lodging". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Thomas Miller accept pharmaceutical money?

Yes, Thomas Miller received this $1.1K payment from Novartis Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Thomas Miller's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $1.1K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Ophthalmology?

To compare this payment against Ophthalmology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Ophthalmology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Thomas Miller's relationship with Novartis Pharmaceuticals?

The payment amount is $1069.75. This $1.1K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Ophthalmology?

The payment was made by Novartis Pharmaceuticals.

What should patients do after learning about this payment?

This information relates to payments made to healthcare providers for travel and lodging. It is important to understand the nature of these payments and how they might relate to your healthcare.

What else should I know about this travel payment?

The payment date was October 9, 2024.

Related Reports

• View Dr. Thomas Miller's full payment report
• Novartis Pharmaceuticals full spending report
• Browse all Ophthalmology payments
• Browse all payments in Missouri
• Search for other payments